Landos Biopharma (LABP) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free LABP Stock Alerts $22.55 +0.06 (+0.27%) (As of 09:44 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLandos Biopharma (LABP) Price Target Increased by 154.20% to 12.96msn.com - April 17 at 10:47 AMStockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVieprnewswire.com - April 16 at 3:32 PMLandos Biopharma, Inc. (NASDAQ:LABP) Short Interest Updatemarketbeat.com - April 10 at 6:50 PMLandos Biopharma, Inc. Expected to Earn Q1 2024 Earnings of ($0.88) Per Share (NASDAQ:LABP)marketbeat.com - April 3 at 6:00 AMHC Wainwright Reiterates Neutral Rating for Landos Biopharma (NASDAQ:LABP)marketbeat.com - April 1 at 8:30 AMLANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABPbusinesswire.com - March 27 at 6:04 PMLandos Biopharma, Inc.: AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseasesfinanznachrichten.de - March 27 at 7:38 AMLeerink Partners Remains a Hold on Landos Biopharma (LABP)markets.businessinsider.com - March 27 at 7:38 AMSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABPprnewswire.com - March 26 at 7:47 PMAbbVie To Acquire Landos Biopharma At $20.42/share In Cashmarkets.businessinsider.com - March 26 at 3:06 AMAbbVie to buy Landos Biopharma for $137 millionbizjournals.com - March 26 at 3:06 AMWhy Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?finance.yahoo.com - March 26 at 3:06 AMWhy Is Landos Biopharma (LABP) Stock Up 168% Today?investorplace.com - March 25 at 12:17 PMShareholder Alert: Ademi LLP investigates whether Landos Biopharma, Inc. has obtained a Fair Price in its transaction with AbbVieprnewswire.com - March 25 at 12:03 PMLABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholdersbusinesswire.com - March 25 at 11:36 AMAbbVie to buy Landos to expand pipeline of immunity-related illnessesreuters.com - March 25 at 8:39 AMAbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseasesprnewswire.com - March 25 at 8:31 AMmarketbeat.com - March 25 at 8:30 AMAbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseasesglobenewswire.com - March 25 at 8:30 AMLABP Stock Earnings: Landos Biopharma Misses EPS for Q4 2023investorplace.com - March 21 at 2:05 PMLandos Biopharma, Inc.: Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Resultsfinanznachrichten.de - March 21 at 11:34 AMRecap: Landos Biopharma Q4 Earningsbenzinga.com - March 21 at 11:34 AMLandos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Resultsglobenewswire.com - March 21 at 8:00 AMXontogeny, LLC's Net Worthbenzinga.com - March 6 at 5:33 PMWill Landos Biopharma (NASDAQ:LABP) Spend Its Cash Wisely?finance.yahoo.com - March 5 at 7:58 AMAmbrx Biopharma Stock (NASDAQ:AMAM) Dividends: History, Yield and Datesbenzinga.com - January 10 at 3:44 PMLandos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisationfinance.yahoo.com - January 8 at 10:06 AMLandos’s NX-13 shows symptom relief in Phase Ib ulcerative colitis trialmsn.com - November 22 at 3:15 PMLandos Biopharma, Inc.: Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn's and Colitisfinanznachrichten.de - November 21 at 1:25 PMLandos Biopharma Shares Rise 10% After Positive Trial Data for NX-13marketwatch.com - November 21 at 1:25 PMLandos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitisfinance.yahoo.com - November 21 at 8:25 AMLandos Biopharma GAAP EPS of -$0.94msn.com - November 9 at 4:33 PMLandos Biopharma: Q3 Earnings Insightsbenzinga.com - November 9 at 9:26 AMLandos Biopharma Provides Company Update and Reports Third Quarter 2023 Resultsfinance.yahoo.com - November 9 at 9:26 AMLandos Biopharma Provides Company Update and Reports Third Quarter 2023 Resultsfinance.yahoo.com - November 9 at 9:26 AMmarketbeat.com - November 1 at 9:51 AMLandos Biopharma to Present at the American College of Gastroenterology 2023 Annual Scientific Meetingfinance.yahoo.com - October 23 at 8:43 AMJonesTrading Sticks to Its Hold Rating for Landos Biopharma (LABP)markets.businessinsider.com - September 22 at 8:26 PMLandos Biopharma to Present New Data on NX-13 from Phase 1b Trial in Ulcerative Colitis at United European Gastroenterology (UEG) Week 2023 Congressfinance.yahoo.com - September 19 at 8:34 AMLandos Biopharma to Present New Data on NX-13 from Phase 1b Trial in Ulcerative Colitis at United European Gastroenterology (UEG) Week 2023 Congressfinance.yahoo.com - September 19 at 8:34 AMLandos Biopharma Announces Strategic Research Collaboration with KU Leuven and University Hospitals Leuven to Further Characterize the Effects of NX-13 on Epithelial Cellsfinance.yahoo.com - September 14 at 9:04 AMLandos Biopharma, Inc.: Landos Biopharma Provides Business Update & Reports Second Quarter 2023 Resultsfinanznachrichten.de - August 9 at 5:31 PMSCPS Scopus BioPharma Inc.seekingalpha.com - August 9 at 12:30 PMLandos Biopharma Provides Business Update & Reports Second Quarter 2023 Resultsfinance.yahoo.com - August 9 at 12:30 PMLandos Biopharma Provides Business Update & Reports Second Quarter 2023 Resultsfinance.yahoo.com - August 9 at 12:30 PMLandos Biopharma to Present at the 2023 Jefferies Healthcare Conferencefinance.yahoo.com - May 31 at 8:09 PMLandos Biopharma, Inc.: Landos Biopharma Announces 1-for-10 Reverse Stock Splitfinanznachrichten.de - May 26 at 11:19 AMLandos Biopharma implements 1-for-10 reverse stock split to regain compliance with Nasdaq requirementsmsn.com - May 25 at 8:26 PMLandos Biopharma Announces 1-for-10 Reverse Stock Splitfinance.yahoo.com - May 25 at 8:26 PMLABP Landos Biopharma, Inc.seekingalpha.com - May 16 at 3:52 PM Get Landos Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LABP and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide LABP Media Mentions By Week LABP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LABP News Sentiment▼1.000.33▲Average Medical News Sentiment LABP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LABP Articles This Week▼11▲LABP Articles Average Week Get Landos Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LABP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Anebulo Pharmaceuticals News Journey Medical News Carisma Therapeutics News Viveon Health Acquisition News Rallybio News Assembly Biosciences News Cue Biopharma News MediciNova News vTv Therapeutics News Corvus Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LABP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Landos Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
